/PRNewswire/ Seegene Inc. (KQ 096530), una empresa de biotecnología especializada en diagnóstico molecular, ha sido reconocida una vez más por su sistema.
Share this article
Share this article
SEOUL, Korea, May 23, 2021 /PRNewswire/ Seegene Inc. (KQ 096530), a biotechnology firm specializing in molecular diagnostics has once again been recognized for its unique system for diagnosing COVID-19 variants at this year s European Congress of Clinical Microbiology, the ECCMID.
Seegene s Dr. Guy Willem Lee, Director of Marketing Strategy introduced the diagnostic system under the theme of SARS-CoV-2 and Variants Full Screening Solution using its latest COVID-19 variant diagnostic tests. The backdrop of Korea s outstanding control at the onset of the pandemic is because of the one-platform diagnostic system that enables mass testing, said Lee. He added that the system enabled the diagnostic process from sample collection through PCR testing all at once, helping local authorities to quickly control the pandemic.
Seegene introduces an exclusive diagnostic system for diagnosing COVID-19 variants at ECCMID finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.